Cargando…

Ocular involvement in TEMPI syndrome

PURPOSE: We report the first case of ocular involvement in TEMPI syndrome, a rare disease characterized by telangiectasias, elevated erythropoietin with erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intra-pulmonary shunting. OBSERVATIONS: A 64-year-old Caucasian man with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jo-Hsuan, Viruni, Narine, Chun, Justin, Shanbhag, Satish, Liu, T.Y. Alvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043672/
https://www.ncbi.nlm.nih.gov/pubmed/35496764
http://dx.doi.org/10.1016/j.ajoc.2022.101534
Descripción
Sumario:PURPOSE: We report the first case of ocular involvement in TEMPI syndrome, a rare disease characterized by telangiectasias, elevated erythropoietin with erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intra-pulmonary shunting. OBSERVATIONS: A 64-year-old Caucasian man with history of TEMPI syndrome presented with subacute bilateral painless vision loss. Ocular examination showed chronic retinal ischemia with microvascular damage, which was likely associated with the chronic systemic hypoxemia, and spontaneous wax and wane of cystoid macular edema, presumedly related to the systemic bortezomib treatment. CONCLUSIONS AND IMPORTANCE: Our case demonstrates that pathologic retinal vascular changes could be seen in association with TEMPI syndrome and suggests that a comprehensive ophthalmological examination may be beneficial for these patients.